Amphastar Pharmaceuticals (AMPH) Construction in Progress (2013 - 2015)
Amphastar Pharmaceuticals (AMPH) posted quarterly Construction in Progress of $29.5 million for Q2 2015, up 49.01% year-over-year from $19.8 million in Q2 2014, and up 3.46% quarter-over-quarter from $28.5 million in Q1 2015.
Amphastar Pharmaceuticals (AMPH) Construction in Progress (2013 - 2015) Analysis & Trends
Amphastar Pharmaceuticals' Construction in Progress history runs 3 years deep, the most recent figure standing at $29.5 million for Q2 2015.
- In Q2 2015, Construction in Progress rose 49.01% year-over-year to $29.5 million; the TTM figure through Jun 2015 stood at $29.5 million (up 49.01% YoY), while the FY2014 annual figure was $25.1 million, up 59.82% from the prior year.
- Construction in Progress for Q2 2015 stood at $29.5 million, up from $28.5 million in the prior quarter.
- The five-year high for Construction in Progress was $29.5 million in Q2 2015, with the low at $15.7 million in Q4 2013.
- The 3-year median for Construction in Progress is $22.7 million (2014), against an average of $23.1 million.
- The sharpest annual moves came in 2014 and 2015: Construction in Progress jumped 59.82% in 2014, then soared 49.01% in 2015.
- Amphastar Pharmaceuticals' Construction in Progress stood at $15.7 million in 2013, then surged by 59.82% to $25.1 million in 2014, then grew by 17.69% to $29.5 million in 2015.
- Business Quant data shows AMPH's Construction in Progress at $29.5 million in Q2 2015, $28.5 million in Q1 2015, and $25.1 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 29.50 Mn |
| Mar 31, 2015 | 28.52 Mn |
| Dec 31, 2014 | 25.07 Mn |
| Sep 30, 2014 | 20.32 Mn |
| Jun 30, 2014 | 19.80 Mn |
| Dec 31, 2013 | 15.69 Mn |